Details for New Drug Application (NDA): 040320
✉ Email this page to a colleague
The generic ingredient in TAPAZOLE is methimazole. There are three drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.
Summary for 040320
Tradename: | TAPAZOLE |
Applicant: | King Pharms Llc |
Ingredient: | methimazole |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040320
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Mar 31, 2000 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Mar 31, 2000 | TE: | RLD: | No |
Complete Access Available with Subscription